SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-054978
Filing Date
2021-04-26
Accepted
2021-04-26 17:09:11
Documents
1
Period of Report
2021-04-22

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2114204-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2114204-2_4seq1.xml 4 3911
  Complete submission text file 0001104659-21-054978.txt   5332
Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Issuer) CIK: 0001744659 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AKERO THERAPEUTICS, INC. 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address
Xu Yuan (Reporting) CIK: 0001858214 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38944 | Film No.: 21854882